Charles River Laboratories
CRL
Operating Margin for Charles River Laboratories (CRL)
Operating Margin as of April 2024 (TTM): 15.02%
According to Charles River Laboratories 's latest financial reports and stock price the company's current Operating Margin is 15.02%. At the end of 2022 the company had an Operating Margin of 15.67%.
Operating Margin history for Charles River Laboratories from 2001 to 2023
Operating Margin at the end of each year
| Year | Operating Margin | Change |
|---|---|---|
| 2022 | 15.67% | 15.39% |
| 2021 | 13.58% | -11.2% |
| 2020 | 15.29% | 31.81% |
| 2019 | 11.60% | -6.67% |
| 2018 | 12.43% | -22.24% |
| 2017 | 15.99% | 20.58% |
| 2016 | 13.26% | -7.51% |
| 2015 | 14.33% | 4.74% |
| 2014 | 13.69% | 15.31% |
| 2013 | 11.87% | 3.32% |
| 2012 | 11.49% | -1.06% |
| 2011 | 11.61% | -139.39% |
| 2010 | -29.48% | -337.72% |
| 2009 | 12.40% | -136.13% |
| 2008 | -34.31% | -294.22% |
| 2007 | 17.67% | 5.91% |
| 2006 | 16.68% | 16.71% |
| 2005 | 14.29% | -28.13% |
| 2004 | 19.89% | -7.97% |
| 2003 | 21.61% | 4.77% |
| 2002 | 20.63% | 38.24% |
| 2001 | 14.92% |
Operating Margin for similar companies or competitors
| Company | Operating Margin | Operating Margin differencediff. | Country |
|---|---|---|---|
 Thermo Fisher Scientific TMO | 14.17% | -5.66% | 🇺🇸 USA |
 SCYNEXIS SCYX | -1,223.94% | -8,248.74% | 🇺🇸 USA |
 Repligen
RGEN | 27.34% | 82.02% | 🇺🇸 USA |
What is a company's Operating Margin
The operating margin is a key indicator to assess the profitability of a company. Higher operating margins are generaly better as they show that a company is able to sell its products or services for much more than their production costs. The operating margin is calculated by dividing a company's earnings by its revenue.